Crossmark

TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma

Published Online: 2022-03-14

Published Print: 2022-12

Authors

Li, Haining

Guo, Liping

Cai, Zhigang
License Information

Text and Data Mining valid from 2022-03-14

Version of Record valid from 2022-03-14
More Information

Article History

Received: 18 November 2021

Accepted: 3 March 2022

First Online: 14 March 2022

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current